DCTH Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 118431 min ago

@ $4.59

Wydano: 13 vas. 2024 @ 16:32

Zwrot: 21.13%

Poprzedni sygnał: vas. 6 - 17:18

Poprzedni sygnał: Sprzedaż

Zwrot: -0.33 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe...

Stats
Dzisiejszy wolumen	76 812.00
Średni wolumen	209 447
Kapitalizacja rynkowa	136.57M
EPS	$0 ( 2024-03-26 )
Następna data zysków	( $-0.430 ) 2024-05-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.890
ATR14	$0.0110 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-19	Aharon Gil	Buy	26 882	Common Shares
2024-03-19	Salamon Steven A J	Buy	26 882	Common Shares
2024-03-19	Rosalind Advisors, Inc.	Buy	619 946	Pre-funded Warrants
2024-03-18	Rook Martha S.	Buy	125 000	Employee Stock Option (Right to Buy)
2024-03-18	Rook Martha S.	Buy	0

INSIDER POWER
93.93
Last 96 transactions
Buy: 8 343 756 \| Sell: 533 108

Wolumen Korelacja

Długi: -0.04 (neutral)

Krótki: -0.85 (strong negative)

Signal:(32.428) Neutral

Delcath Systems Inc Korelacja

10 Najbardziej pozytywne korelacje
META	0.947
JBSS	0.939
MANH	0.938
DSGX	0.937
CIFR	0.933
INOD	0.932
NVCT	0.932
IOAC	0.932
ASO	0.932
LIBY	0.931

10 Najbardziej negatywne korelacje
NCBS	-0.944
TSHA	-0.922
BWB	-0.915
GSMG	-0.915
IPA	-0.911
ALRS	-0.903
HLIO	-0.902
COFS	-0.901
CYRN	-0.9
GXGX	-0.899

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Delcath Systems Inc Korelacja - Waluta/Towar

-0.27
( neutral )

-0.31
( neutral )

0.00
( neutral )

0.45
( neutral )

-0.41
( neutral )

Delcath Systems Inc Finanse

Annual	2023
Przychody:	$2.07M
Zysk brutto:	$1.30M (63.05 %)
EPS:	$-2.94

FY	2023
Przychody:	$2.07M
Zysk brutto:	$1.30M (63.05 %)
EPS:	$-2.94

FY	2022
Przychody:	$2.72M
Zysk brutto:	$2.03M (74.77 %)
EPS:	$-4.42

FY	2021
Przychody:	$3.56M
Zysk brutto:	$2.88M (81.13 %)
EPS:	$-8.85

Financial Reports:

No articles found.

Delcath Systems Inc

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.